Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
Giovanna Li Petri(University of Palermo), Elisa Giovannetti(University of Pisa), Larry H. Matherly(Wayne State University), Giulia Mantini(Fondazione Pisa), Btissame El Hassouni(Amsterdam University Medical Centers), Godefridus J. Peters(Gdańsk Medical University), Tonny Lagerweij(Amsterdam University Medical Centers), Niccola Funel(IMT School for Advanced Studies Lucca), Rocco Sciarrillo(Amsterdam University Medical Centers), Kees Smid(Vrije Universiteit Amsterdam), Patrizia Diana(University of Palermo), Paolo Andrea Zucali(Humanitas University), Alicja Braczko(Gdańsk Medical University), Barbara Parrino(University of Palermo), Marcello Deraco(Fondazione IRCCS Istituto Nazionale dei Tumori), Eveline A. Zeeuw van der Laan(Amsterdam University Medical Centers), Jacqueline Cloos(Vrije Universiteit Amsterdam), Ryszard T. Smoleński(Gdańsk Medical University), Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Filippo Minutolo(University of Pisa), Stella Cascioferro(University of Palermo), Carlotta Granchi(University of Pisa), Gerrit Jansen(Amsterdam UMC Location VUmc), Amir Avan(University of Pisa), Yehuda G. Assaraf(Technion – Israel Institute of Technology)
Cited by 42
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2018|1k
Fluorouracil: biochemistry and pharmacology.
|Journal of Clinical Oncology|1988|834